Immunogenicity of eight dormancy regulon-encoded proteins of Mycobacterium tuberculosis in DNA-vaccinated and tuberculosis-infected mice

Infection and Immunity

Volumn 75, Issue 2, 2007, Pages 941-949

  Roupie, Virginie ^a   Romano, Marta ^a   Zhang, Lei ^b   Korf, Hannelie ^a   May, Young Lin ^c   Franken, Kees L M C ^c   Ottenhoff, Tom H M ^c   Klein, Michèl R ^c,d   Huygen, Kris ^a  

^a PASTEUR INSTITUTE OF BRUSSELS   (Belgium)

^b Chengdu Institute of Biological Products   (China)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; EPITOPE; GAMMA INTERFERON; INTERLEUKIN 2; ISONIAZID; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PLASMID DNA; PYRAZINAMIDE;

ADOLESCENT; ANIMAL EXPERIMENT; ARTICLE; BACTERIAL SURVIVAL; BAGG ALBINO MOUSE; C57BL MOUSE; CELLULAR IMMUNITY; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE EXPRESSION; HUMORAL IMMUNITY; IMMUNOGENICITY; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PERSISTENT INFECTION; PRIORITY JOURNAL; REGULON; T LYMPHOCYTE; TH1 CELL; TUBERCULOSIS; VACCINATION;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; EPITOPE MAPPING; EPITOPES, B-LYMPHOCYTE; EPITOPES, T-LYMPHOCYTE; FLOW CYTOMETRY; GENETIC VECTORS; IMMUNODOMINANT EPITOPES; IMMUNOGLOBULIN G; INTERFERON TYPE II; INTERLEUKIN-2; LYMPHOCYTE SUBSETS; LYMPHOCYTES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MYCOBACTERIUM TUBERCULOSIS; PLASMIDS; REGULON; TUBERCULOSIS; TUBERCULOSIS VACCINES; VACCINES, DNA;

EID: 33846786584     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.01137-06     Document Type: Article

References (46)

1. Achonu, C., F. Jamieson, M. A. Behr, T. Lillebaek, K. Khan, and M. Gardam. 2006. Evidence for local transmission and reactivation of tuberculosis in the Toronto Somali community. Scand. J. Infect. Dis. 38:778-781.
2. Arriaga, A. K., E. H. Orozco, L. D. Aguilar, G. A. W. Rook, and R. Hernandez-Pando. 2002. Immunological and pathological comparative analysis between experimental latent tuberculous infection and progressive pulmonary tuberculosis. Clin. Exp. Immunol. 128:229-237.
3. Bandera, A., A. Gori, L. Catozzi, A. Degli Esposti, G. Marchetti, C. Molteni, G. Ferrario, L. Codecasa, V. Penati, A. Matteelli, and F. Franzetti. 2001. Molecular epidemiological study of exogenous reinfection in an area with a low incidence of tuberculosis. J. Clin. Microbiol. 39:2213-2218.
4. Betts, J. C., P. T. Lukey, L. C. Robb, R. A. McAdam, and K. Duncan. 2002. Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression. Mol. Microbiol. 43:717-731.
5. Boon, C., and T. Dick. 2002. Mycobacterium bovis BCG response regulator essential for hypoxic dormancy. J. Bacteriol. 184:6760-6767.
6. Boon, C. R., R. Li, R. Qi, and T. Dick. 2001. Proteins of Mycobacterium bovis BCG induced in the Wayne dormancy model. J. Bacteriol. 183:2672-2676.
7. Caccamo, N., A. Barera, C. Di Sano, S. Meraviglia, J. Ivanyi, F. Hudecz, S. Bosze, F. Dieli, and A. Salerno. 2003. Cytokine profile, HLA restriction and TCR sequence analysis of human CD4+ T clones specific for an immunodominant epitope of Mycobacterium tuberculosis 16-kDa protein. Clin. Exp. Immunol. 133:260-266.
8. + T lymphocytes, J. Infect. Dis. 186:991-998.
9. Canetti, G., I. Sutherland, and E. Svandova. 1972. Endogenous reactivation and exogenous reinfection: their relative importance with regard to the development of non-primary tuberculosis. Bull. Int. Union Tuberc. 47:116-134.
10. Corbett, E. L., C. J. Watt, N. Walker, D. Maher, B. G. Williams, M. C. Raviglione, and C. Dye. 2003. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch. Intern. Med. 163:1009-1021.
11. Cunningham, A. F., and C. L. Spreadbury. 1998. Mycobacterial stationary phase induced by low oxygen tension: cell wall thickening and localization of the 16-kilodalton alpha-crystallin homolog. J. Bacteriol. 180:801-808.
12. Demissie, A., E. M. Leyten, M. Abebe, L. Wassie, A. Aseffa, G. Abate, H. A. Fletcher, P. Owiafe, P. C. Hill, R. Brookes, G. Rook, A. Zumla, S. M. Arend, M. R. Klein, T. H. Ottenhoff, P. Andersen, T. M. Doherty, and the VACSEL Study Group. 2006. Recognition of stage-specific mycobacterial antigens differentiates between acute and latent infections with Mycobacterium tuberculosis. Clin. Vaccine Immunol. 13:179-186.
13. Denis, O., E. Lozes, and K. Huygen. 1997. Induction of cytotoxic T-cell responses against culture filtrate antigens in Mycobacterium bovis bacillus Calmette-Guérin-infected mice. Infect. Immun. 65:676-684.
14. + T cells activated in vivo by Mycobacterium tuberculosis or bovis BCG recognize a restricted number of immunodominant peptides. Immunol. Lett. 81:115-124.
15. + T-cell epitopic repertoire broader than that stimulated by Mycobacterium tuberculosis H37Rv infection. Infect. Immun. 66:1527-1533.
16. D'Souza, S., V. Rosseels, O. Denis, A. Tangbe, N. De Smet, F. Jurion, K. Palfliet, N. Castiglioni, A. Vanonckelen, C. Wheeler, and K. Huygen. 2002. Improved tuberculosis DNA vaccines by formulation in cationic lipids. Infect. Immun. 70:3681-3688.
17. D'Souza, S., V. Rosseels, M. Romano, A. Tanghe, O. Denis, F. Jurion, N. Castiglioni, A. Vanonckelen, K. Palfliet, and K. Huygen. 2003. Mapping of murine Th1 helper T-cell epitopes of mycolyl transferases Ag85A, Ag85B and Ag85C from Mycobacterium tuberculosis. Infect. Immun. 71:483-493.
18. Feller, D. C., and V. F. de La Cruz. 1991. Identifying antigenic T-cell sites. Nature 349:720-721.
19. Fine, P. E. M. 1995. Variation in protection by BCG: implications of and for heterologous immunity. Lancet 346:1339-1345.
20. Fisher, M. A., B. B. Plikaytis, and T. M. Shinnick. 2002. Microarray analysis of the Mycobacterium tuberculosis transcriptional response to the acidic conditions found in phagosomes. J. Bacteriol. 184:4025-4032.
21. Flynn, J. L., and J. Chan. 2001. Tuberculosis: latency and reactivation. Infect. Immun. 69:4195-4201.
22. Franken, K. L., H. S. Hiemstra, K. E. van Meijgaarden, Y. Subronto, J. den Hartigh, T. H. M. Ottenhoff, and J. W. Drijfhout. 2000. Purification of his-tagged proteins by immobilized chelate affinity chromatography: the benefits from the use of organic solvents. Protein Exper. Purif. 18:95-99.
23. Geluk, A., K. E. van Meijgaarden, K. L. M. C. Franken, J. W. Drijfhout, S. D'Souza, A. Necker, K. Huygen, and T. H. M. Ottenhoff. 2000. Identification of major epitopes of Mycobacterium tuberculosis Ag85B that are recognized by HLA-A*0201 restricted CD8+ T cells in HLA-transgenic mice and humans. J. Immunol. 165:6463-6471.
24. Hu, Y., F. Movahedzadeh, N. G. Stoker, and A. R. M. Coates. 2006. Deletion of the Mycobacterium tuberculosis α-crystallin-like hspX gene caused increased bacterial growth in vivo. Infect. Immun. 74:861-868.
25. Huygen, K., J. Content, O. Denis, D. L. Montgomery, A. M. Yawman, R. R. Deck, C. M. DeWitt, I. M. Orme, S. Baldwin, C. D'Souza, A. Drowart, E. Lozes, P. Vandenbussche, J.-P. Van Vooren, M. A. Liu, and J. B. Ulmer. 1996. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nat. Med. 2:893-898.
26. Jackett, P. S., G. H. Bothamley, H. V. Batra, A. Mistry, D. B. Young, and J. Ivanyi. 1988. Specificity of antibodies to immunodominant mycobacterial antigens in pulmonary tuberculosis. J. Clin. Microbiol. 26:2313-2318.
27. Jungblut, P. R., U. E. Schaible, H. J. Möllenkopf, U. Zimny-Arndt, B. Raupach, J. Mattow, P. Halada, S. Lamer, K. Hagens, and S. H. E. Kaufmann. 1999. Comparative proteome analysis of Mycobacterium tuberculosis and Mycobacterium bovis BCG strains: towards functional genomics of microbial pathogens. Mol. Microbiol. 33:1103-1117.
28. Karakousis, P. C., T. Yoshimatsu, G. Lamichhane, S. C. Woolwine, E. L. Nuermberger, J. Grosset, and W. R. Bishai. 2004. Dormancy phenotype displayed by extracellular Mycobacterium tuberculosis within artificial granulomas in mice. J. Exp. Med. 200:647-657.
29. Lee, B. Y., S. A. Hefta, and P. J. Brennan. 1992. Characterization of the major membrane protein of virulent Mycobacterium tuberculosis. Infect. Immun. 60:2066-2074.
30. Leyten, E. M., M. Y. Lin, K. L. Franken, A. H. Friggen, C. Prins, K. E. van Meijgaarden, M. I. Voskuil, K. Weldingh, P. Andersen, G. K. Schoolnik, S. M. Arend, T. H. Ottenhoff, and M. R. Klein. 2006. Human T-cell responses to 25 novel antigens encoded by genes of the dormancy regulon of Mycobacterium tuberculosis. Microbes Infect. 8:2052-2060.
31. Noss, E. H., R. K. Pai, T. J. Sellati, J. D. Radolf, J. Belisle, D. T. Golenbock, W. H. Boom, and C. V. Harding. 2001. Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by a 19-kDa lipoprotein of Mycobacterium tuberculosis. J. Immunol. 167:910-918.
32. Raja, A., K. R. Uma Devi, B. Ramalingam, and P. J. Brennan. 2002. Immunoglobulin G, A, and M responses in serum and circulating immune complexes elicited by the 16-kilodalton antigen of Mycobacterium tuberculosis. Clin. Diagn. Lab. Immunol. 9:308-312.
33. b restricted cytolytic T cell activity against a putative phosphate transport receptor of M. tuberculosis. J. Immunol. 172:6913-6921.
34. Romano, M., S. D'Souza, P. Y. Adnet, R. Laali, F. Jurion, K. Palfliet, and K. Huygen. 2006. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from M. tuberculosis increases the survival time of M. bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv. Vaccine. 24:3353-3364.
35. Rosenkrands, I., R. A. Slayden, J. Crawford, C. Aagard, C. E. Barry III, and P. Andersen. 2002. Hypoxic response of Mycobacterium tuberculosis studied by metabolic labeling and proteasome analysis of cellular and extracellular proteins. J. Bacteriol. 184:3485-3491.
36. Scanga, C. A., V. P. Mohan, K. Yu, H. Joseph, K. E. Tanaka, J. Chan, and J. L. Flynn. 2000. Depletion of CD4+ T cells causes reactivation of murine persistent tuberculosis despite continued expression of interferon-γ and nitric oxide synthase 2. J. Exp. Med. 192:347-358.
37. Schnappinger, D., S. Ehrt, M. I. Voskuil, Y. Liu, J. A. Mangan, I. M. Monahan, G. Dolganov, B. Efron, and P. D. Butcher. 2003. Transcriptional adaptation of Mycobacterium tuberculosis within macrophages: insights into the phagosomal environment. J. Exp. Med. 198:693-704.
38. Sherman, D. R., M. Voskuil, D. Schnappinger, R. Liao, M. I. Harrell, and G. K. Schoolnik. 2001. Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding alpha-crystallin. Proc. Natl. Acad. Sci. USA 98:7534-7539.
39. Shi, L., Y. J. Jung, S. Tyagi, M. L. Gennaro, and R. J. North. 2003. Expression of Th1-mediated immunity in mouse lungs induces a Mycobacterium tuberculosis transcription pattern characteristic of non-replicating persistence. Proc. Natl. Acad. Sci. USA 100:241-246.
40. Tanghe, A., S. D'Souza, V. Rosseels, O. Denis, T. H. M. Ottenhoff, W. Dalemans, C. Wheeler, and K. Huygen. 2001. Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting. Infect. Immun. 69:3041-3047.
41. van Pinxteren, L. A. H., J. P. Cassidy, B. H. C. Smedegaard, E. M. Agger, and P. Andersen. 2000. Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells. Eur. J. Immunol. 30:3689-3698.
42. Vekemans, J., M. O. C. Ota, J. Sillah, K. Fielding, M. R. Alderson, Y. A. W. Skeiky, W. Dalemans, K. P. W. J. McAdam, C. Lienhardt, and A. Marchant. 2004. Immune responses to mycobacterial antigens in the Gambian population: implications for vaccines and immunodiagnostic test design. Infect. Immun. 72:381-388.
43. Vordermeier, H. M., D. P. Harris, R. Lathigra, E. Roman, C. Moreno, and J. Ivanyi. 1993. Recognition of peptide epitopes of the 16,000 MW antigen of Mycobacterium tuberculosis by murine T cells. Immunology 80:6-12.
44. Voskuil, M. I., D. Schnappinger, K. C. Visconti, M. I. Harrell, G. M. Dolganov, D. R. Sherman, and G. K. Schoolnik. 2003. Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program. J. Exp. Med. 198:705-713.
45. Wayne, L. G., and C. D. Sohaskey. 2001. Nonreplicating persistence of Mycobacterium tuberculosis. Annu. Rev. Microbiol. 55:139-163.
46. Yuan, Y., D. D. Crane, R. M. Simpson, Y. Zhu, M. Hickey, D. R. Sherman, and C. E. Barry III. 1998. The 16-kDa α-crystallin (Acr) protein Of Mycobacterium tuberculosis is required for growth in macrophages. Proc. Natl. Acad. Sci. USA 95:9578-9583.